RankingsPricing
  1. US-listed companies
  2. ABBOTT LABORATORIES
  3. Financials
  4. Common stock and paid-in capital

ABBOTT LABORATORIESABT

Market cap
$221.4B
P/E ratio
SummaryFinancials
Period EndCommon stock and paid-in capital (Million USD)YoY (%)
Dec 31, 202425,153+1.14%
Dec 31, 202324,869+0.65%
Dec 31, 202224,709+0.98%
Dec 31, 202124,470+1.35%
Dec 31, 202024,145+1.22%
Dec 31, 201923,853+1.45%
Dec 31, 201823,512+1.32%
Dec 31, 201723,206+78.14%
Dec 31, 201613,027+2.30%
Dec 31, 201512,734+2.83%
Dec 31, 201412,383+2.78%
Dec 31, 201312,048+37.77%
Dec 31, 20108,745

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)